1. Tasić T, Tadić M, Lozić M. Hypertension in Women. Front Cardiovasc Med. 2022 Jun 3;9:905504. doi: 10.3389/fcvm.2022.905504. PMID: 35722103; PMCID: PMC9203893.
2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957–980. doi: 10.1016/S0140-6736(21)01330-1.
3. Wenger NK, Arnold A, Bairey Merz CN, Cooper-DeHoff RM, Ferdinand KC, Fleg JL, Gulati M, Isiadinso I, Itchhaporia D, Light-McGroary K, Lindley KJ, Mieres JH, Rosser ML, Saade GR, Walsh MN, Pepine CJ. Hypertension Across a Woman's Life Cycle. J Am Coll Cardiol. 2018 Apr 24;71(16):1797-1813. doi: 10.1016/j.jacc.2018.02.033. PMID: 29673470; PMCID: PMC6005390.
4. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. (2011) 25:391–403. 10.1016/j.bpobgyn.2011.01.006.
5. Wenger NK, Arnold A, Merz CNB, Cooper-DeHoff RM, Ferdinand KC, Fleg JL, et al.. Hypertension across a woman's life cycle. J Am Coll Cardiol. (2018) 71:1797–813. 10.1016/j.jacc.2018.02.033.
6. Brahmbhatt Y, Gupta M, Hamrahian S. Hypertension in premenopausal and postmenopausal women. Curr Hypertens Rep. (2019) 21:74. 10.1007/s11906-019-0979-y.
7. McBride SM, Flynn FW, Ren J. Cardiovascular alteration and treatment of hypertension: do men and women differ? Endocrine. (2005) 28:199–207. 10.1385/ENDO:28:2:199.
8. Leuzzi C, Modena MG. Hypertension in postmenopausal women: pathophysiology and treatment. High Blood Press Cardiovasc Prev. (2011) 18:13–8. 10.2165/11588030-000000000-00000.
9. Engberding N, Wenger NK. Management of hypertension in women. Hypertens Res. (2012) 35:251–60. 10.1038/hr.2011.210.